Nucleocardyl en es it fr

Nucleocardyl Brand names, Nucleocardyl Analogs

Nucleocardyl Brand Names Mixture

  • No information avaliable

Nucleocardyl Chemical_Formula


Nucleocardyl RX_link

Nucleocardyl fda sheet

Nucleocardyl FDA

Nucleocardyl msds (material safety sheet)

Nucleocardyl MSDS

Nucleocardyl Synthesis Reference

No information avaliable

Nucleocardyl Molecular Weight

267.242 g/mol

Nucleocardyl Melting Point

235.5 oC

Nucleocardyl H2O Solubility

8230 mg/L

Nucleocardyl State


Nucleocardyl LogP


Nucleocardyl Dosage Forms


Nucleocardyl Indication

For controlling paroxysmal supraventricular tachycardia (PSVT). This drug can also be used diagnostically for stable, wide complex tachyardias of unknown type.

Nucleocardyl Pharmacology

Adenosine is an endogenous nucleoside occurring in all cells of the body and is not chemically related to other antiarrhythmic drugs. Adenosine is indicated for the conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). Adenosine is antagonized competitively by methylxanthines such as caffeine and theophylline, and potentiated by blockers of nucleoside transport such as dipyridamole. Adenosine is not blocked by atropine.

Nucleocardyl Absorption

No information avaliable

Nucleocardyl side effects and Toxicity

No information avaliable

Nucleocardyl Patient Information

No information avaliable

Nucleocardyl Organisms Affected

Humans and other mammals